Primo, D., Scarfò, L., Xochelli, A., Mattsson, M., Ranghetti, P., Espinosa, A. B., . . . Ghia, P. (2018). A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia. Oncotarget.
استشهاد بنمط شيكاغوPrimo, Daniel, et al. "A Novel Ex Vivo High-throughput Assay Reveals Antiproliferative Effects of Idelalisib and Ibrutinib in Chronic Lymphocytic Leukemia." Oncotarget 2018.
MLA استشهادPrimo, Daniel, et al. "A Novel Ex Vivo High-throughput Assay Reveals Antiproliferative Effects of Idelalisib and Ibrutinib in Chronic Lymphocytic Leukemia." Oncotarget 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.